Corrigendum

This article refers to:

The safety of mepolizumab for the treatment of asthma

Leung E, Al Efraij K, FitzGerald JM. The safety of mepolizumab for the treatment of asthma. Expert Opin Drug Saf. 2017 Feb 1:1–8. Available from http://dx.doi.org/10.1080/14740338.2017.1286327

When the above article was first published online, the department names in the affiliations for E Leung^a and K Al Efraij^b were incorrect. These have now been corrected in both the online and print versions of the article, and they are provided below.

^aDepartment of Internal Medicine, University of British Columbia - Vancouver, Canada;

^bDepartment of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, Canada;

The author apologizes for this error.